{"disease":{"id":"influenza-immunisation","name":"influenza immunisation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04398706","title":"Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":852,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03312231","title":"Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06793826","title":"Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea","phase":"","overall_status":"COMPLETED","enrollment_count":713,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT04429295","title":"Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT03682120","title":"Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03738241","title":"2017 A/H7N9 IIV Revaccination","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03945825","title":"Flublok or Fluzone With Advax-CpG55.2 or AF03","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04451954","title":"Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT03589807","title":"2013/2017 H7N9 Prime-Boost Interval","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03328325","title":"Age and Response to Flu Vaccines","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03318315","title":"Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03673345","title":"Development of Childhood Anti-Influenza Immunity","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03058692","title":"Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02251288","title":"A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02385123","title":"Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":60,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03472976","title":"H5N1 With or Without Topical Aldara in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03553940","title":"H3N2 M2SR in Pediatric Population","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02485639","title":"Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}